Login to Your Account

Pharma: Other News To Note

Tuesday, July 9, 2013
• GW Pharmaceuticals plc, of Porton Down, UK, said its cannabinoid product Sativex, for use in the treatment of moderate to severe spasticity in multiple sclerosis, is now available in Italy through its partner Almirall S.A., of Barcelona, Spain.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription